MetaHeps®, our in vitro solution to enhance safety in clinical safety
Quickly enhance your clinical trials through MetaHeps, our platform to assessing patient-specific adverse liver reactions based on blood samples
The MetaHeps® technology platform supports clinical trials by providing an improved assessment of adverse reactions of the liver based on isolated and re-differentiated blood cells. This unique technology helps identify hepatotoxicity or DILI risks early and with precision, significantly reducing the risk of unsuccessful trials. Moreover, it streamlines the drug approval process by providing essential data to regulatory authorities, expediting the time required to bring a drug to market. With its straightforward implementation directly into the clinical trial protocol, MetaHeps provides trial sponsors with an exceptional safeguard against unforeseen safety concerns.
Why Clinical Safety with InSphero?
Your Success is Our Mission
Schedule a consultation with our experts